Literature DB >> 8377907

Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.

M Cordes1, B J Snow, S Morrison, V Sossi, T J Ruth, D B Calne.   

Abstract

Positron emission tomography (PET) studies using [18F]-L-dopa were carried out in 9 patients with supranuclear palsy and 13 controls. For quantification of PET data a rate constant Ki was calculated for the radiotracer using a graphical method. Corrections for nonspecific activity were performed in both arterial plasma and brain tissue. The purpose of this study was to test the hypothesis that parametric images of the rate constant K mapping can be obtained on a pixel-by-pixel basis using an appropriate mathematical algorithm. Ki values from these parametric images and the graphical approach were compared. Both correlated closely, with y = 0.013 + 0.947*x, r = 0.992 and y = -0.052 + 1.018*x, r = 0.965 in patients and controls, respectively. Contrast measurements were also performed and showed a striking increase in contrast on parametric images. K mapping offers several advantages over the graphical approach, since parametric images are time-independent, i.e. one image represents the quantitative result of the study. In addition, parametric images of the rate constant are normalized to arterial plasma radioactivity and corrected for tissue metabolites. Thus, parametric images of Ki in different individuals can be compared directly without further processing in order to assess the nigrostriatal integrity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377907     DOI: 10.1007/bf00602816

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  (18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.

Authors:  G Firnau; E S Garnett; T L Sourkes; K Missala
Journal:  Experientia       Date:  1975-11-15

2.  Nigrostriatal function in humans studied with positron emission tomography.

Authors:  W R Martin; M R Palmer; C S Patlak; D B Calne
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

3.  Blood-brain barrier transport and cerebral utilization of dopa in living monkeys.

Authors:  E S Garnett; G Firnau; C Nahmias; S Sood; L Belbeck
Journal:  Am J Physiol       Date:  1980-05

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  D J Brooks; V Ibanez; G V Sawle; N Quinn; A J Lees; C J Mathias; R Bannister; C D Marsden; R S Frackowiak
Journal:  Ann Neurol       Date:  1990-10       Impact factor: 10.422

7.  Dopamine visualized in the basal ganglia of living man.

Authors:  E S Garnett; G Firnau; C Nahmias
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

8.  Routine determination of [18F]-L-6-fluorodopa and its metabolites in blood plasma is essential for accurate positron emission tomography studies.

Authors:  G L Chan; K A Hewitt; B D Pate; P Schofield; M J Adam; T J Ruth
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

9.  Positron emission tomography in Shy-Drager syndrome.

Authors:  M H Bhatt; B J Snow; W R Martin; S Cooper; D B Calne
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.